226 related articles for article (PubMed ID: 32326614)
21. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial.
ten Hoedt AE; de Sonneville LM; Francois B; ter Horst NM; Janssen MC; Rubio-Gozalbo ME; Wijburg FA; Hollak CE; Bosch AM
J Inherit Metab Dis; 2011 Feb; 34(1):165-71. PubMed ID: 21153445
[TBL] [Abstract][Full Text] [Related]
22. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
[TBL] [Abstract][Full Text] [Related]
23. Future role of large neutral amino acids in transport of phenylalanine into the brain.
Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
[TBL] [Abstract][Full Text] [Related]
24. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
Jahja R; Huijbregts SCJ; de Sonneville LMJ; van der Meere JJ; Legemaat AM; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Neuropsychology; 2017 May; 31(4):437-447. PubMed ID: 28318283
[TBL] [Abstract][Full Text] [Related]
25. Long-term cognitive and psychosocial outcomes in adults with phenylketonuria.
Aitkenhead L; Krishna G; Ellerton C; Moinuddin M; Matcham J; Shiel L; Hossain S; Kiffin M; Foley J; Skeath R; Cleary M; Lachmann R; Murphy E
J Inherit Metab Dis; 2021 Nov; 44(6):1353-1368. PubMed ID: 34145605
[TBL] [Abstract][Full Text] [Related]
26. Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.
van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Kema IP; Heiner-Fokkema MR; van Anholt RD; van der Zee EA; van Spronsen FJ
PLoS One; 2015; 10(12):e0143833. PubMed ID: 26624009
[TBL] [Abstract][Full Text] [Related]
27. Cognitive outcomes in early-treated adults with phenylketonuria (PKU): A comprehensive picture across domains.
Palermo L; Geberhiwot T; MacDonald A; Limback E; Hall SK; Romani C
Neuropsychology; 2017 Mar; 31(3):255-267. PubMed ID: 28080075
[TBL] [Abstract][Full Text] [Related]
28. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine metabolism in health and disease: slow-release amino acids therapy improves tyrosine homeostasis in phenylketonuria.
Porta F; Giorda S; Ponzone A; Spada M
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1519-1523. PubMed ID: 33581706
[TBL] [Abstract][Full Text] [Related]
30. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
31. Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.
MacDonald A; Singh RH; Rocha JC; van Spronsen FJ
Nutr Res Rev; 2019 Jun; 32(1):70-78. PubMed ID: 30284526
[TBL] [Abstract][Full Text] [Related]
32. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
[TBL] [Abstract][Full Text] [Related]
34. [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients].
Gutiérrez-Mata AP; Vilaseca MA; Capdevila-Cirera A; Vidal-Oller M; Alonso-Colmenero I; Colomé R; López-Sala A; Lambruschini-Ferri N; Gutiérrez A; Gassió R; Artuch R; Campistol J
Rev Neurol; 2012 Aug; 55(4):200-6. PubMed ID: 22829083
[TBL] [Abstract][Full Text] [Related]
35. Effects of dietary mixtures of amino acids on fetal growth and maternal and fetal amino acid pools in experimental maternal phenylketonuria.
Austic RE; Su CL; Strupp BJ; Levitsky DA
Am J Clin Nutr; 1999 Apr; 69(4):687-96. PubMed ID: 10197570
[TBL] [Abstract][Full Text] [Related]
36. A preliminary report on dopamine system reactivity in PKU: acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions.
Luciana M; Hanson KL; Whitley CB
Psychopharmacology (Berl); 2004 Aug; 175(1):18-25. PubMed ID: 15024549
[TBL] [Abstract][Full Text] [Related]
37. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
[TBL] [Abstract][Full Text] [Related]
38. Influence of blood phenylalanine level variations on the development of executive functions and social cognition in children with phenylketonuria.
de Almeida Duarte CM; Piazzon FB; Rocco IS; de Mello CB
J Pediatr (Rio J); 2023; 99(5):507-513. PubMed ID: 37178714
[TBL] [Abstract][Full Text] [Related]
39. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
Sharman R; Sullivan K; Young R; McGill J
Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
[TBL] [Abstract][Full Text] [Related]
40. Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients.
Luna PM; López-Paz JF; García M; Amayra I; Martínez O; Pérez M; Rodríguez AA; Pérez-Núñez P; Ceberio I; Mansilla N; Soria C
Behav Neurol; 2023; 2023():9681740. PubMed ID: 36815863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
